Paul Dayton
See the following -
Kitware to Develop Quantitative Cancer Assessment Environment
Kitware, a leading-edge software R&D and consulting provider, today announces the award of $298,436 in Phase I SBIR funding from the National Institutes of Health. The funding will be used to develop an ultrasound-based quantitative diagnostic approach for assessing tumor malignancy and predicting tumor outcomes. Read More »
- Login to post comments
NIH Awards $1.26 Million to Kitware and Collaborators for Cancer Treatment Research: Are Microvessels Early Indicators of Cancer Treatment Efficacy?
The research project is centered on a novel approach to cancer detection and diagnosis that is based on using acoustic angiography to measure small changes in the microvessels that feed tumors. Acoustic angiography is a contrast-enhanced ultrasound imaging technique that is being developed by Dr. Paul Dayton at The University of North Carolina at Chapel Hill (UNC), who is a principal investigator on the project. The technique can provide unprecedented clarity in visualizing microvascular abnormalities associated with malignant cancers that resolve when those cancers respond to treatment.
- Login to post comments